论文部分内容阅读
笔者对16例肺癌并阻塞性肺不张患者进行~(18)F-脱氧葡萄糖(FDG)PET/CT 显像,探讨其临床价值,现报道如下。一、资料与方法1.临床资料。2003年8月~2004年11月肺癌合并阻塞性肺不张患者16例,男12例,女4例,年龄42~74岁,平均57.4岁。均经病理检查证实,其中鳞癌6例,腺癌7例,小细胞癌2例,腺鳞癌1例。行 PET/CT 显像前8例尚未治疗,5例行化疗,3例行放化疗。2.方法。~(18)F-FDG由 GE PETtrace 回旋加速器及 Microlab
The author of 16 cases of lung cancer and obstructive atelectasis in patients with ~ (18) F-glucose (FDG) PET / CT imaging, to explore its clinical value, are reported below. First, data and methods 1. Clinical data. August 2003 ~ November 2004 lung cancer patients with obstructive atelectasis in 16 cases, 12 males and 4 females, aged 42 to 74 years, mean 57.4 years. Confirmed by pathological examination, of which 6 cases of squamous cell carcinoma, adenocarcinoma in 7 cases, 2 cases of small cell carcinoma, adenosquamous carcinoma in 1 case. 8 cases before PET / CT imaging have not yet been treated, 5 cases of chemotherapy, 3 cases of radiotherapy and chemotherapy. Method. ~ (18) F-FDG consists of GE PETtrace cyclotron and Microlab